DADC
SANA icon

D.A. Davidson & Co’s Sana Biotechnology SANA Stock Holding History

D.A. Davidson & Co’s Portfolio SANA Stock Details SANA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-11,220
Closed -$39.8K – 1598
2025
Q3 		$39.8K Sell
11,220
-2,000
-15% -$7.23K ﹤0.01% 1506
2025
Q2 		$36.1K Sell
13,220
-1,480
-10% -$3.05K ﹤0.01% 1425
2025
Q1 		$24.7K Hold
14,700
– – ﹤0.01% 1391
2024
Q4 		$24K Sell
14,700
-16,880
-53% -$50.3K ﹤0.01% 1404
2024
Q3 		$131K Sell
31,580
-4,000
-11% -$21K ﹤0.01% 1331
2024
Q2 		$194K Buy
35,580
+13,380
+60% +$107K ﹤0.01% 1290
2024
Q1 		$222K Buy
+22,200
New +$166K ﹤0.01% 1270

Other funds holding SANA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
MG
Marex Group London $23.6B AUM 57.16% 1-Year Est. Return
IHAM
Integral Health Asset Management New York $2.53B AUM 154.61% 1-Year Est. Return

D.A. Davidson & Co's SANA Position: Q4 2025 in Review

D.A. Davidson & Co sold out of Sana Biotechnology (SANA) in Q4 2025, closing a stake of 11,220 shares — an estimated $39.8K sold.

D.A. Davidson & Co first reported a position in SANA in Q1 2024 and held it in 7 quarters. The position peaked at $222K in Q1 2024. 203 funds tracked by Wall St. Rank hold SANA as of Q4 2025.

  • D.A. Davidson & Co reported no remaining Sana Biotechnology position as of Q4 2025 after selling out during the quarter.
  • D.A. Davidson & Co sold 11,220 Sana Biotechnology shares in Q4 2025, an estimated $39.8K.
  • D.A. Davidson & Co first reported a position in Sana Biotechnology in Q1 2024 and held it in 7 quarters.
  • D.A. Davidson & Co's Sana Biotechnology position peaked at $222K in Q1 2024.
  • 203 funds tracked by Wall St. Rank held Sana Biotechnology as of Q4 2025.

Based on D.A. Davidson & Co's 13F filing for Q4 2025, filed 29 Jan 2026.